Novel patch-based systems for the localised delivery of ALA-esters

Journal of Photochemistry and Photobiology B: Biology

Volumn 101, Issue 1, 2010, Pages 59-69

  Morrow, Desmond I J ^a,c   McCarron, Paul A ^b   Woolfson, A David ^a   Juzenas, Petras ^d   Juzeniene, Asta ^c   Iani, Vladimir ^c   Moan, Johan ^c   Donnelly, Ryan F ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

5 Aminolaevulinic acid; Drug delivery; Esters; Patches; Prodrugs; Topical

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; IN VITRO STUDY; LIPOPHILICITY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SKIN PENETRATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; CARCINOMA, BASAL CELL; DISEASE MODELS, ANIMAL; ESTERS; MICE; MICROSCOPY, FLUORESCENCE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN NEOPLASMS; SWINE; TISSUE ADHESIVES;

MUS; SUS;

EID: 77955659019     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2010.06.012     Document Type: Article

References (45)

1. Daniell M.D., Hill J.S. A history of photodynamic therapy. Aust. NZ. J. Surg. 1991, 61:340-348.
2. De Rosa F.S., Bentley M.V. Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives. Pharm. Res. 2000, 17:1447-1455.
3. Lopez R.F., Lange N., Guy R., Bentley M.V. Photodynamic therapy of skin cancer: controlled drug delivery of 5-ALA and its esters. Adv. Drug Deliv. Rev. 2004, 56:77-94.
4. Uehlinger P., Zellweger M., Wagnieres G., Juillerat-Jeanneret L., van den Bergh H., Lange N. 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells. J. Photochem. Photobiol. B 2000, 54:72-80.
5. Donnelly R.F., Morrow D.I., McCarron P.A., Garland M.J., Woolfson A.D. Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting. J. Photochem. Photobiol. B 2007, 89:98-109.
6. Donnelly R.F., Morrow D.I., McCarron P.A., Woolfson A.D., Morrissey A., Juzenas P., Juzeniene A., Iani V., McCarthy H.O., Moan J. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J. Control. Release 2008, 129:154-162.
7. Merclin N., Bender J., Sparr E., Guy R.H., Ehrsson H., Engstrom S. Transdermal delivery from a lipid sponge phase - iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J. Control. Release 2004, 100:191-198.
8. Dabrowski Z., Kwasny M., Kaminski J., Beldowicz M., Lewicka L., Obukowicz B., Kaliszewski M., Pirozynska E. The synthesis and applications of 5-aminolevulinic acid (ALA) derivatives in photodynamic therapy and photodiagnosis. Acta Pol. Pharm. 2003, 60:219-224.
9. Kloek J., Akkermans W., Beijersbergen van Henegouwen G.M. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 1998, 67:150-154.
10. Kloek J., Beijersbergen van H. Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem. Photobiol. 1996, 64:994-1000.
11. Eleouet S., Rousset N., Carre J., Bourre L., Vonarx V., Lajat Y., Beijersbergen van Henegouwen G.M., Patrice T. In vitro fluorescence, toxicity and phototoxicity induced by delta-aminolevulinic acid (ALA) or ALA-esters. Photochem. Photobiol. 2000, 71:447-454.
12. Xiang W., Weingandt H., Liessmann F., Klein S., Stepp H., Baumgartner R., Hillemanns P. Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture. Photochem. Photobiol. 2001, 74:617-623.
13. Rodriguez L., de Bruijn H.S., Di Venosa G., Mamone L., Robinson D.J., Juarranz A., Batlle A., Casas A. Porphyrin synthesis from aminolevulinic acid esters in endothelial cells and its role in photodynamic therapy. J. Photochem. Photobiol. B 2009, 96:249-254.
14. Winkler A., Muller-Goymann C.C. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum. Eur. J. Pharm. Biopharm. 2005, 60:427-437.
15. Winkler A., Muller-Goymann C.C. Comparative permeation studies for delta-aminolevulinic acid and its n-butylester through stratum corneum and artificial skin constructs. Eur. J. Pharm. Biopharm. 2002, 53:281-287.
16. De Rosa F.S., Tedesco A.C., Lopez R.F., Pierre M.B., Lange N., Marchetti J.M., Rotta J.C., Bentley M.V. In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy. J. Control. Release 2003, 89:261-269.
17. D.I.J. Morrow, P.A. McCarron, A.D. Woolfson, P. Juzenas, A. Juzeniene, V. Iani, J. Moan, R.F. Donnelly, Hexyl aminolevulinate is a more effective topical photosensitiser than methyl aminolevulinate and 5-aminolevulinic acid when applied in equimolar doses, J. Pharm. Sci. in press.
18. Juzeniene A., Juzenas P., Iani V., Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem. Photobiol. 2002, 76:329-334.
19. van den Akker J.T., Iani V., Star W.M., Sterenborg H.J., Moan J. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol. 2000, 72:681-689.
20. McCarron P.A., Donnelly R.F., Zawislak A., Woolfson A.D. Design and evaluation of a water-soluble bioadhesive patch formulation for cutaneous delivery of 5-aminolevulinic acid to superficial neoplastic lesions. Eur. J. Pharm. Sci. 2006, 27:268-279.
21. McCarron P.A., Donnelly R.F., Zawislak A., Woolfson A.D., Price J.H., McClelland R. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions. Int. J. Pharm. 2005, 293:11-23.
22. Morrow D.I.J., McCarron P.A., Woolfson A.D., Donnelly R.F. Practical considerations in the pharmaceutical analysis of methyl and hexyl ester derivatives of 5-aminolevulinic acid. Open Anal. Chem. J. 2009, 3:6-15.
23. Bronaugh R.L., Stewart R.F., Congdon E.R. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 1982, 62:481-488.
24. Donnelly R.F., Morrow D.I., McCarron P.A., Juzenas P., Woolfson A.D. Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues. J. Photochem. Photobiol. B 2006, 82:59-71.
25. A.C. Williams, Transdermal and Topical Drug Delivery, Pharmaceutical Press, London, 2003.
26. Pulaski B.A., Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 1998, 58:1486-1493.
27. Peng Q., Moan J., Warloe T., Iani V., Steen H.B., Bjorseth A., Nesland J.M. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J. Photochem. Photobiol. B 1996, 34:95-96.
28. Brown L., Langer R. Transdermal delivery of drugs. Annu. Rev. Med. 1988, 39:221-229.
29. Meidan V.M., Michniak B.B. Emerging technologies in transdermal therapeutics. Am. J. Ther. 2004, 11:312-316.
30. Bretschko E., Szemies R., landthaler M., Lee G. Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. evaluation of stratum corneum permeability in vitro. J. Control. Release 1996, 42:203-208.
31. Lieb S., Szeimies R.M., Lee G. Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. Eur. J. Pharm. Biopharm. 2002, 53:99-106.
32. P. Pons, P. Roald, B. Nestor, G. Rafael, A. Agustin, Transdermic patches for photodynamic therapy of superficial lesions, in: Proceedings of the 29th Annual Meeting of the American Society of Photobiology, 2001.
33. McCarron P.A., Donnelly R.F., Woolfson A.D., Zawislak A. Photodynamic therapy of vulval intraepithelial neoplasia using bioadhesive patch-based delivery of aminolevulinic acid. Drug Deliv. Syst. Sci. 2003, 3:59-64.
34. Anders R., Merkle H.P. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 1989, 49:231-240.
35. Zawislak A.A., McCarron P.A., McCluggage W.G., Donnelly R.F., Price J.H., McClelland H.R., Woolfson A.D. Preliminary evaluation of a novel bioadhesive patch-type system for the photodynamic therapy of vulvodynia following delivery of 5-aminolevulinic acid. J. Reprod. Med. 2007, 52:645-653.
36. McCarron P.A., Donnelly R.F., Woolfson A.D., Zawislak A., Price J.H., Maxwell P. Photodynamic treatment of lichen sclerosus and squamous hyperplasia using sustained topical delivery of aminolevulinic acid from a novel bioadhesive. Br. J. Dermatol. 2004, 151(Suppl. 68):105-106.
37. McCarron P.A., Ma L.W., Juzenas P., Lani V., Woolfson A., Zawislak A.A., Moan J. Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems. J. Environ. Pathol. Toxicol. Oncol. 2006, 25:389-402.
38. Morrow D.I.J., McCarron P.A., Woolfson A.D., Donnelly R.F. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv. J. 2007, 1:36-59.
39. Donnelly R.F., Juzenas P., McCarron P.A., Ma L., Woolfson A.D., Moan J. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. PDPDT 2006, 3:190-201.
40. Sorenson R., Juzenas P., Iani V., Moan J. Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. Proc. SPIE 1999, 3563:77-81.
41. Moan J., Ma L.W., Juzeniene A., Iani V., Juzenas P., Apricena F., Peng Q. Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int. J. Cancer 2003, 103:132-135.
42. Donnelly R.F., Ma L.W., Juzenas P., Iani V., McCarron P.A., Woolfson A.D., Moan J. Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation in tumours. Photochem. Photobiol. 2006, 82:670-675.
43. Moan J., Ma L.W., Iani V. On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int. J. Cancer 2001, 92:139-143.
44. Yung A., Stables G.I., Fernandez C., Williams J., Bojar R.A., Goulden V. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream. Clin. Exp. Dermatol. 2007, 32:716-721.
45. Dognitz N., Salomon D., Zellweger M., Ballini J.P., Gabrecht T., Lange N., van den Bergh H., Wagnieres G. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J. Photochem. Photobiol. B 2008, 93:140-148.